233 related articles for article (PubMed ID: 33894903)
1. A conceptual framework to accelerate the clinical impact of evolving research into long COVID.
Kondratiuk AL; Pillay TD; Kon OM; Lalvani A
Lancet Infect Dis; 2021 Jun; 21(6):756-757. PubMed ID: 33894903
[No Abstract] [Full Text] [Related]
2. Navigating the social identity of long covid.
Van de Vyver J; Leite AC; Alwan NA
BMJ; 2021 Nov; 375():n2933. PubMed ID: 34836878
[No Abstract] [Full Text] [Related]
3. Consequences of COVID-19 for cancer care - a CRUK perspective.
Greenwood E; Swanton C
Nat Rev Clin Oncol; 2021 Jan; 18(1):3-4. PubMed ID: 33097915
[TBL] [Abstract][Full Text] [Related]
4. Long COVID and kids: more research is urgently needed.
Nature; 2022 Feb; 602(7896):183. PubMed ID: 35136225
[No Abstract] [Full Text] [Related]
5. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection.
Trinkmann F; Müller M; Reif A; Kahn N; Kreuter M; Trudzinski F; Eichinger M; Heussel CP; Herth FJF;
Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 33479105
[TBL] [Abstract][Full Text] [Related]
6. Long COVID and chronic COVID syndromes.
Halpin S; O'Connor R; Sivan M
J Med Virol; 2021 Mar; 93(3):1242-1243. PubMed ID: 33034893
[No Abstract] [Full Text] [Related]
7. Understanding and tracking the impact of long COVID in the United Kingdom.
Routen A; O'Mahoney L; Ayoubkhani D; Banerjee A; Brightling C; Calvert M; Chaturvedi N; Diamond I; Eggo R; Elliott P; Evans RA; Haroon S; Herret E; O'Hara ME; Shafran R; Stanborough J; Stephenson T; Sterne J; Ward H; Khunti K
Nat Med; 2022 Jan; 28(1):11-15. PubMed ID: 34811549
[No Abstract] [Full Text] [Related]
8. Impact of COVID-19 on in vivo work and patient sample availability for cancer research.
Mulholland EJ
Nat Rev Cancer; 2021 Mar; 21(3):139-140. PubMed ID: 33462500
[TBL] [Abstract][Full Text] [Related]
9. Unpacking "long COVID".
Murray T
CMAJ; 2021 Mar; 193(9):E318-E319. PubMed ID: 33649174
[No Abstract] [Full Text] [Related]
10. Long covid: new wine in need of new bottles.
Banerjee A
BMJ; 2021 Nov; 375():n2736. PubMed ID: 34753712
[No Abstract] [Full Text] [Related]
11. US health agency will invest $1 billion to investigate 'long COVID'.
Subbaraman N
Nature; 2021 Mar; 591(7850):356. PubMed ID: 33664445
[No Abstract] [Full Text] [Related]
12. AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care.
Williams PA; Zaidi SK; Sengupta R
Clin Cancer Res; 2022 Feb; 28(4):609-610. PubMed ID: 35140125
[No Abstract] [Full Text] [Related]
13. COVID-19 impact on oncology clinical trials: a 1-year analysis.
Upadhaya S; Yu JX; Hodge J; Campbell J
Nat Rev Drug Discov; 2021 Jun; 20(6):415. PubMed ID: 34002059
[No Abstract] [Full Text] [Related]
14. Diversifying the biomedical workforce during the COVID-19 pandemic.
Nguyen LH; Tan-McGrory A; Oh AY; Barreto EA; Bartels SJ; Armstrong KA; Chan AT; Warner ET
Nat Med; 2020 Dec; 26(12):1811. PubMed ID: 33128050
[No Abstract] [Full Text] [Related]
15. Clinical Science Editorial 2020 - a year gone by and the year ahead.
Touyz RM
Clin Sci (Lond); 2020 Dec; 134(24):3233-3235. PubMed ID: 33313696
[TBL] [Abstract][Full Text] [Related]
16. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
Smith SM; Wachter K; Burris HA; Schilsky RL; George DJ; Peterson DE; Johnson ML; Markham MJ; Mileham KF; Beg MS; Bendell JC; Dreicer R; Keedy VL; Kimple RJ; Knoll MA; LoConte N; MacKay H; Meisel JL; Moynihan TJ; Mulrooney DA; Mulvey TM; Odenike O; Pennell NA; Reeder-Hayes K; Smith C; Sullivan RJ; Uzzo R
J Clin Oncol; 2021 Apr; 39(10):1165-1184. PubMed ID: 33527845
[No Abstract] [Full Text] [Related]
17. Audio Interview: The Future of Covid-19 Research.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2023 Mar; 388(11):e39. PubMed ID: 36920766
[No Abstract] [Full Text] [Related]
18. A model framework for projecting the prevalence and impact of Long-COVID in the UK.
Martin C; Luteijn M; Letton W; Robertson J; McDonald S
PLoS One; 2021; 16(12):e0260843. PubMed ID: 34855874
[TBL] [Abstract][Full Text] [Related]
19. Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021.
Ojelade M; Rodriguez A; Gonzalez D; Otokunrin D; Ramachandruni S; Cuevas E; Moon K; Tyler CG; Freeland M; Anderson M; Haire K; Orozco Y; Scipio F; Springer Y; Prot E; Shuford JA
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(10):348-349. PubMed ID: 33705368
[TBL] [Abstract][Full Text] [Related]
20. Pandemic corona virus issue - how do we respond?
Kurjak A
J Perinat Med; 2020 Jun; 48(5):426-427. PubMed ID: 32415825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
